Neurotechnology company receives $35 million R&D funding to cure sleep problems

July 11th, 2018

Dreem is a neurotechnology company that is currently working on a state of the art product which could potentially end sleeping problems and enhance people’s quality of rest during the night. The company has just been granted $35 million R&D funding to accelerate its latest product and invest into further research and development to advance its technology.

The product is a ‘Dreem headband’ which monitors brain activity to track sleep accurately and use auditory stimulation as a medium to help people fall asleep faster and enhance their sleep in order to wake up refreshed.

Dreem has big plans to bring their new sleep technology across the globe and this latest round of funding will enable this to happen. Additionally the $35 million funding will also allow for continued R&D investment for future sleep-rated scientific discoveries and innovations.

Approximately 30% of people don’t sleep effectively and improving this in society would unleash opportunities like none other in terms of human productivity and creativity.

Dream has a mission to become the accessible, universally effective solution for everyone on the planet suffering from poor sleep quality.

Company’s developing novel solutions such as Dreem are greatly supported by the government and can be eligible to receive an R&D Tax Incentive.  Swanson Reed R&D Tax Consultants help companies to claim this incentive and help ensure that companies receive the maximum eligible amount. Take our online eligibility quiz to find out whether you qualify for a tax rebate.

Post a Comment

(*) indicates required field.